IRS-2 deficiency in macrophages promotes their accumulation in the vascular wall.
暂无分享,去创建一个
W. L. Jin | T. Kadowaki | R. Kawamori | H. Watada | N. Kubota | K. Tobe | R. Suzuki | T. Hirose | T. Nomiyama | Y. Fujitani | T. Mita | Hiromasa Goto | M. Arakawa | K. Azuma | Wen Long Jin
[1] W. L. Jin,et al. Impact of insulin resistance on enhanced monocyte adhesion to endothelial cells and atherosclerogenesis independent of LDL cholesterol level. , 2010, Biochemical and biophysical research communications.
[2] R. Kawamori,et al. Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4 , 2010, Diabetes.
[3] Yi Lu,et al. FoxO1 Links Insulin Resistance to Proinflammatory Cytokine IL-1β Production in Macrophages , 2009, Diabetes.
[4] HerminiaGonzález-Navarro,et al. Molecular Mechanisms of Atherosclerosis in Metabolic Syndrome , 2008 .
[5] M. Horie,et al. In Vivo and In Vitro Inhibition of Monocyte Adhesion to Endothelial Cells and Endothelial Adhesion Molecules by Eicosapentaenoic Acid , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[6] D. Burks,et al. Molecular Mechanisms of Atherosclerosis in Metabolic Syndrome: Role of Reduced IRS2-Dependent Signaling , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[7] Simon J. Walker,et al. Effect of Endothelium-Specific Insulin Resistance on Endothelial Function In Vivo , 2008, Diabetes.
[8] Alexander S. Banks,et al. Forkhead Transcription Factors (FoxOs) Promote Apoptosis of Insulin-Resistant Macrophages During Cholesterol-Induced Endoplasmic Reticulum Stress , 2008, Diabetes.
[9] S. Jancar,et al. Insulin Inhibits LPS-Induced Signaling Pathways in Alveolar Macrophages , 2008, Cellular Physiology and Biochemistry.
[10] R. Kawamori,et al. Impact of whole body irradiation and vascular endothelial growth factor-A on increased beta cell mass after bone marrow transplantation in a mouse model of diabetes induced by streptozotocin , 2008, Diabetologia.
[11] R. Kawamori,et al. Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice. , 2007, Biochemical and biophysical research communications.
[12] A. Tall,et al. The Macrophage at the Crossroads of Insulin Resistance and Atherosclerosis , 2007, Circulation research.
[13] G. Freund,et al. Type 2 Diabetes Impairs Insulin Receptor Substrate-2-Mediated Phosphatidylinositol 3-Kinase Activity in Primary Macrophages to Induce a State of Cytokine Resistance to IL-4 in Association with Overexpression of Suppressor of Cytokine Signaling-31 , 2007, The Journal of Immunology.
[14] C. Kahn,et al. Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis (DOI:10.1016/j.cmet.2006.02.010) , 2006 .
[15] A. Dart,et al. Insulin resistance and atherosclerosis. , 2006, Endocrine reviews.
[16] D. Accili,et al. Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. , 2006, Cell metabolism.
[17] D. Accili,et al. Increased CD36 protein as a response to defective insulin signaling in macrophages. , 2004, The Journal of clinical investigation.
[18] B. Draznin,et al. Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. , 2003, Diabetes.
[19] R. Kawamori,et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells , 2003, Diabetologia.
[20] RyozoNagai,et al. Lack of Insulin Receptor Substrate-2 Causes Progressive Neointima Formation in Response to Vessel Injury , 2003 .
[21] C. Kahn,et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. , 2003, The Journal of clinical investigation.
[22] T. Asano,et al. Insulin Up-regulates Tumor Necrosis Factor-α Production in Macrophages through an Extracellular-regulated Kinase-dependent Pathway* , 2001, The Journal of Biological Chemistry.
[23] A. Aljada,et al. Insulin Inhibits Intranuclear Nuclear Factor κB and Stimulates IκB in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect? , 2001 .
[24] A. Aljada,et al. Insulin Inhibits NFκB and MCP-1 Expression in Human Aortic Endothelial Cells , 2001 .
[25] A. Aljada,et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? , 2001, The Journal of clinical endocrinology and metabolism.
[26] A. Aljada,et al. Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells. , 2001, The Journal of clinical endocrinology and metabolism.
[27] S. Aizawa,et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. , 2000, Diabetes.
[28] B. Rollins,et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[29] P. Libby,et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.
[30] D. Schneider,et al. Dependence of augmentation of arterial endothelial cell expression of plasminogen activator inhibitor type 1 by insulin on soluble factors released from vascular smooth muscle cells. , 1997, Circulation.
[31] G. Dagenais,et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. , 1996, The New England journal of medicine.